Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RB Says Petya Cyberattack Froze Shipments, Could Cost £100M

Executive Summary

Beiersdorf and Merck also were impacted by the June 27 malware attack that rocked the globe, but RB's the only one of the three that's in any way quantified the hit it sustained. The blow comes at an unfortunate time for the UK-based company, whose first-quarter performance was its weakest in 15 years.

You may also be interested in...



Dr Reddy's Isolates Data Service Centers Among Preventive Actions Responding To Cyberattack

Following cyberattack, chief information officer Mukesh Rathi said Dr Reddy's was “anticipating all services to be up within 24 hours,” adding that “we do not foresee any major impact on our operations due to this incident.”

Infant Formula Production Stalls On Reckitt Benckiser's Latest Stumble

A "technical problem" interrupted infant formula production at firm's Netherlands plant during third quarter, causing a 8% dive in its revenues from Enfamil and other brand formulas. The problem has been corrected but revenues will be slowed during the current quarter and likely into early 2019.  But analysts say the imapct could be deeper impact because it's the fourth problems since 2011 RB should have avoided.

Reckitt At '2.0' On Nutrition Market Expansion But Question No. 1 Remains, Potential Pfizer Consumer Bid?

UK firm sees acquisitions of Mead Johnson Nutrition and the Schiff brand as major milestones in its trajectory as a consumer health market competitor, but market analysts say both would be rendered comparatively minor moves if it makes an offer to acquire Pfizer's consumer products business. Mead Johnson's Enfamil NeuroPro infant formula line extension formulated with "milk fat globule membrane" and DHA should be available in US in March or April.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS121057

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel